From the Canadian Press:
Formulas for new, inexpensive influenza drugs that could expand the world's tiny arsenal of weapons against pandemic flu are gathering dust because the pharmaceutical industry isn't interested in developing them, scientists say.
They believe governments should fund the testing and development of the drugs, side-stepping big pharma and bringing them to market as cheap generic medications. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment